|
|
|
Issue Open Date
|
13-Nov-24
|
|
|
|
Issue Closing Date
|
18-Nov-24
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
58
-
61
|
|
|
|
Minimium Application No.
|
2000
|
|
|
|
Issue Size (Shares)
|
3444000
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.3. Prepayment or repayment of all or a portion of certain loans availed by our Company.4. General Corporate Purposes.
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
|
415166000
|
|
|
Qualified Institutional Buyers
|
|
29634000
|
|
|
Retail Individual Investors
|
|
190978000
|
|
|
|
|
|
Business Description
Onyx started its operation in pharmaceutical industry with sterile water for injections in the year 2010. Since then,Onyx has been associated with the healthcare segment and offering Sterile Pharmaceutical products and has becomea prominent supplier of sterile products to major corporations, which includes the top pharma companies at pan Indialevel. Onyx is committed to provide high-quality products at affordable price. Presently, our Company manufacturesSterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range ofDry Powder Injections and Dry Syrup for India and overseas. Our products are being processed and manufactured inaccordance with best FDA practices available globally. Our system and product is tested constantly at each level toensure international standards of quality in-house and FDA Certified Laboratories. Our core business is focused onproviding end-to-end product development and manufacturing solutions to our clients. Our service also includepreparation and filing of regulatory dossiers in the Indian and global markets.
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
11803200
|
|
|
|
Offered to Public
|
4810000
|
|
|
|
Promoter's Holding (Pre-Issue)
|
88.6
|
|
|
|
Promoter's Holding (Post-Issue)
|
65.1
|
|
|
|
|
|
|
|
|
|
|
Address |
Bir Plassi Near Sainimajraropar
Nalagarh Road
Solan Dist,
Himachal Pradesh,
174101
Phone :
Email : generalinfo@onyxbiotec.com
Website : www.onyxbiotec.com
|
|
|
Registrar |
MAS Services Ltd
T-34
2nd Floor
Okhla Industrial Area
Phase - II
New Delhi
|
|
|
Listed at |
|
NSE
|
|
|
Lead Manager |
|
Horizon Management Pvt Ltd.
|
|
|
Promoters |
Fateh Pal Singh
Harsh Mahajan
Lakshya Jain
Naresh Kumar
Parmjeet Kaur
Sanjay Jain
|
|
